Relay Therapeutics Inc. Stock Prediction and Forecast [RLAY]

AI-generated source summary

The analysis of Relay Therapeutics Inc. stock (RLAY) presents a predominantly bearish outlook. Despite a recent slight gain on the last trading day, the stock is categorized as a "Sell Candidate" with a negative score. Multiple technical indicators, including short and long-term Moving Averages, MACD, and pivots, are issuing sell signals, contributing to a negative forecast for the near future. Fundamental data shows a negative P/E ratio, further supporting a weak performance prediction. Current price is $7.41, with immediate support at $6.86 and resistance at $7.60. The overall evaluation suggests the stock is overvalued and is expected to perform weakly in the coming days or weeks.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   21 Jan 2026, 03:56 UTC

   The analyst published the original source item.

2. First prediction resolved

   21 Jan 2026, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   21 Jan 2026, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:14 UTC

   Tahlil Plus began monitoring the extracted predictions.